Known adverse effects of SGLT2 inhibitors are diabetic ketoacidosis, urinary tract infections, genital infections, cutaneous adverse drug reactions (CADRs), bone fractures, and rare reports of cancer [13,14,15,16,17,18]. This evidence concerns the gene SLC5A2 and diabetic ketoacidosis.